Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 31;17(10):7875-7885.
doi: 10.21037/jtd-2025-1203. Epub 2025 Oct 27.

Long-term outcomes after pleural decortication for patients with chronic sterile, non-malignant pleural effusion

Affiliations

Long-term outcomes after pleural decortication for patients with chronic sterile, non-malignant pleural effusion

Hee Chul Yang et al. J Thorac Dis. .

Abstract

Background: While decortication is well-established for empyema or malignancy, its role in chronic sterile, non-malignant pleural effusions (CSNMPE) remains unclear. Given the high mortality rate among patients with CSNMPE, further longitudinal studies are warranted to assess the long-term efficacy and survival outcomes associated with decortication in this population. This study assesses long-term outcomes of decortication in CSNMPE and considers implications for future management.

Methods: Between January 1, 2012, and December 31, 2022, a total of 25 patients underwent pleural decortication for CSNMPE at a single institution.

Results: Median age was 67 years, with male predominance (84%) and right-sided effusions (64%). Etiologies were cardiac (28%), multifactorial (20%), hepatic (16%), renal (16%), unknown (12%), and autoimmune (8%). The median time from initial detection of pleural effusion to decortication was 6.6 months. Minimally invasive approach was used in 52% (thoracotomy, 48%). Radiographic improvement with significant lung re-expansion (>75%) was observed in 80%, and 72% experienced symptom relief. Postoperative complications occurred in 36%. Median overall survival was 65.3 months, with 1-, 3-, and 5-year survival rates of 80.0%, 63.8%, and 50.1%, respectively. Factors associated with decreased survival included a history of cancer treatment (P<0.01), prolonged pleural effusion duration (P=0.01), and increased intraoperative blood loss (P<0.01).

Conclusions: Pleural decortication may benefit selected CSNMPE patients unresponsive to conservative therapy, offering symptom relief and survival. Findings are exploratory, and potential advantages of early intervention require further prospective validation.

Keywords: Pleura; chest tube; fibrothorax; heart failure; thoracentesis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-1203/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Inclusion of patients with chronic sterile non-malignant pleural effusion.
Figure 2
Figure 2
Pleural effusion etiology.
Figure 3
Figure 3
Overall survival curve in patients with decortication.

References

    1. Jany B, Welte T. Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment. Dtsch Arztebl Int 2019;116:377-86. 10.3238/arztebl.2019.0377 - DOI - PMC - PubMed
    1. Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med 2012;4:31-52. 10.2147/OAEM.S29942 - DOI - PMC - PubMed
    1. Quinn T, Alam N, Aminazad A, et al. Decision making and algorithm for the management of pleural effusions. Thorac Surg Clin 2013;23:11-6, v. 10.1016/j.thorsurg.2012.10.009 - DOI - PubMed
    1. Rathinam S, Waller DA. Pleurectomy decortication in the treatment of the “trapped lung” in benign and malignant pleural effusions. Thorac Surg Clin 2013;23:51-61, vi. 10.1016/j.thorsurg.2012.10.007 - DOI - PubMed
    1. Kim S, Park H, Cho YK, et al. Refractory Pleural Effusion in Systemic Lupus Erythematosus Treated by Pleurectomy. J Rheum Dis 2017;24:43-7.

LinkOut - more resources